edetic acid has been researched along with Bisphosphonate Osteonecrosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, P; Awad, ME; Baladhandayutham, B; Elsalanty, ME; Elsayed, R; Kurago, Z; McKenna, CE; Pashley, DH; Whitford, GM | 1 |
1 other study(ies) available for edetic acid and Bisphosphonate Osteonecrosis
| Article | Year |
|---|---|
Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function.
Topics: Amino Acids; Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone and Bones; Calcium; Cell Differentiation; Cell Proliferation; Chelating Agents; Diphosphonates; Edetic Acid; Humans; Jaw; Mass Spectrometry; Mice; Molar; Osteoclasts; Rats; Rats, Sprague-Dawley; RAW 264.7 Cells; Tooth Extraction; X-Ray Microtomography; Zoledronic Acid | 2018 |